Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 11 | 2025 | 170 | 6.420 |
Why?
|
| Anticoagulants | 5 | 2025 | 477 | 2.050 |
Why?
|
| Emergency Service, Hospital | 23 | 2024 | 1021 | 2.030 |
Why?
|
| Outpatients | 2 | 2023 | 136 | 1.430 |
Why?
|
| Noninvasive Ventilation | 2 | 2020 | 70 | 1.310 |
Why?
|
| Opioid-Related Disorders | 4 | 2024 | 456 | 1.220 |
Why?
|
| Heparin, Low-Molecular-Weight | 2 | 2025 | 26 | 1.140 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2024 | 64 | 1.050 |
Why?
|
| Physicians | 2 | 2022 | 426 | 1.050 |
Why?
|
| Qualitative Research | 4 | 2025 | 618 | 1.030 |
Why?
|
| Hospitalization | 4 | 2025 | 1290 | 0.930 |
Why?
|
| Emergency Medicine | 4 | 2024 | 181 | 0.900 |
Why?
|
| Cannula | 2 | 2020 | 25 | 0.880 |
Why?
|
| Harm Reduction | 1 | 2024 | 29 | 0.860 |
Why?
|
| Restraint, Physical | 1 | 2023 | 33 | 0.840 |
Why?
|
| Humans | 48 | 2025 | 59282 | 0.820 |
Why?
|
| Transsexualism | 1 | 2022 | 13 | 0.790 |
Why?
|
| Buprenorphine | 2 | 2022 | 181 | 0.750 |
Why?
|
| Transgender Persons | 1 | 2022 | 62 | 0.730 |
Why?
|
| Sexual and Gender Minorities | 1 | 2022 | 70 | 0.710 |
Why?
|
| Emergency Medical Services | 2 | 2023 | 255 | 0.710 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 141 | 0.690 |
Why?
|
| Electric Countershock | 2 | 2020 | 99 | 0.670 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2025 | 687 | 0.650 |
Why?
|
| Periodicals as Topic | 1 | 2022 | 166 | 0.650 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 90 | 0.650 |
Why?
|
| Patient Discharge | 1 | 2023 | 489 | 0.640 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 1479 | 0.640 |
Why?
|
| Betacoronavirus | 1 | 2020 | 166 | 0.600 |
Why?
|
| Occupational Diseases | 1 | 2020 | 263 | 0.600 |
Why?
|
| Coronavirus Infections | 2 | 2021 | 191 | 0.590 |
Why?
|
| Patient Safety | 1 | 2020 | 237 | 0.580 |
Why?
|
| Retrospective Studies | 10 | 2024 | 6071 | 0.570 |
Why?
|
| Patient Care Team | 1 | 2020 | 326 | 0.560 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 292 | 0.560 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 204 | 0.550 |
Why?
|
| Health Personnel | 1 | 2020 | 340 | 0.540 |
Why?
|
| Spinal Puncture | 1 | 2016 | 15 | 0.520 |
Why?
|
| Headache | 1 | 2016 | 54 | 0.510 |
Why?
|
| Rivaroxaban | 1 | 2015 | 19 | 0.500 |
Why?
|
| Pain Management | 2 | 2021 | 146 | 0.460 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 110 | 0.460 |
Why?
|
| Analgesics | 1 | 2015 | 96 | 0.460 |
Why?
|
| Social Media | 3 | 2022 | 117 | 0.440 |
Why?
|
| Heparin | 2 | 2025 | 111 | 0.440 |
Why?
|
| Patient Satisfaction | 2 | 2020 | 412 | 0.420 |
Why?
|
| ST Elevation Myocardial Infarction | 2 | 2024 | 73 | 0.400 |
Why?
|
| Analgesia | 2 | 2022 | 30 | 0.380 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 805 | 0.380 |
Why?
|
| Acute Disease | 2 | 2024 | 659 | 0.350 |
Why?
|
| Adult | 12 | 2025 | 15663 | 0.340 |
Why?
|
| Female | 11 | 2025 | 30695 | 0.340 |
Why?
|
| United States | 8 | 2024 | 7385 | 0.330 |
Why?
|
| Male | 10 | 2025 | 27727 | 0.330 |
Why?
|
| Policy | 3 | 2024 | 47 | 0.320 |
Why?
|
| Intubation, Intratracheal | 2 | 2020 | 194 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 1525 | 0.260 |
Why?
|
| Middle Aged | 6 | 2025 | 16310 | 0.250 |
Why?
|
| Seizures | 1 | 2024 | 113 | 0.220 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2024 | 103 | 0.210 |
Why?
|
| Naloxone | 1 | 2024 | 57 | 0.210 |
Why?
|
| Aged | 7 | 2024 | 13412 | 0.210 |
Why?
|
| Shoulder Dislocation | 1 | 2022 | 9 | 0.210 |
Why?
|
| Brain Concussion | 1 | 2023 | 28 | 0.200 |
Why?
|
| Fibrinolytic Agents | 1 | 2024 | 163 | 0.200 |
Why?
|
| Fear | 1 | 2023 | 65 | 0.200 |
Why?
|
| Point-of-Care Testing | 1 | 2023 | 43 | 0.200 |
Why?
|
| Appendicitis | 1 | 2023 | 74 | 0.200 |
Why?
|
| Anesthesia | 1 | 2022 | 48 | 0.200 |
Why?
|
| Guideline Adherence | 1 | 2025 | 290 | 0.200 |
Why?
|
| Blood Transfusion | 1 | 2023 | 150 | 0.190 |
Why?
|
| Nurses | 1 | 2023 | 102 | 0.190 |
Why?
|
| Gender Identity | 1 | 2022 | 62 | 0.190 |
Why?
|
| Analgesics, Opioid | 2 | 2024 | 483 | 0.190 |
Why?
|
| Methoxyflurane | 1 | 2021 | 1 | 0.190 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2021 | 8 | 0.180 |
Why?
|
| Brain Injuries | 1 | 2023 | 135 | 0.180 |
Why?
|
| Point-of-Care Systems | 1 | 2023 | 119 | 0.180 |
Why?
|
| Ureterolithiasis | 1 | 2021 | 11 | 0.180 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 42 | 0.180 |
Why?
|
| Accidental Falls | 1 | 2022 | 124 | 0.180 |
Why?
|
| Ambulatory Care | 1 | 2023 | 300 | 0.180 |
Why?
|
| Network Meta-Analysis | 1 | 2020 | 12 | 0.170 |
Why?
|
| Abscess | 1 | 2021 | 76 | 0.170 |
Why?
|
| Wounds and Injuries | 1 | 2023 | 229 | 0.170 |
Why?
|
| Drainage | 1 | 2021 | 148 | 0.170 |
Why?
|
| Recurrence | 1 | 2022 | 602 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 100 | 0.170 |
Why?
|
| Comorbidity | 1 | 2023 | 1078 | 0.170 |
Why?
|
| Accountable Care Organizations | 1 | 2020 | 60 | 0.160 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 179 | 0.160 |
Why?
|
| Drug Overdose | 1 | 2020 | 126 | 0.150 |
Why?
|
| Occupational Exposure | 1 | 2020 | 306 | 0.140 |
Why?
|
| Coma | 1 | 2017 | 13 | 0.140 |
Why?
|
| Hypothermia, Induced | 1 | 2017 | 40 | 0.140 |
Why?
|
| Cultural Diversity | 1 | 2017 | 52 | 0.140 |
Why?
|
| Resuscitation | 1 | 2017 | 69 | 0.130 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2017 | 46 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 5128 | 0.130 |
Why?
|
| Medicare | 1 | 2020 | 598 | 0.130 |
Why?
|
| Asthma | 1 | 2020 | 452 | 0.130 |
Why?
|
| Head | 1 | 2016 | 53 | 0.130 |
Why?
|
| Faculty, Medical | 1 | 2017 | 192 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2017 | 132 | 0.120 |
Why?
|
| Internship and Residency | 1 | 2023 | 740 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 614 | 0.120 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 93 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 724 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 730 | 0.120 |
Why?
|
| Contrast Media | 1 | 2017 | 408 | 0.120 |
Why?
|
| Massachusetts | 1 | 2020 | 2003 | 0.120 |
Why?
|
| Child | 1 | 2023 | 4173 | 0.110 |
Why?
|
| Data Collection | 1 | 2015 | 371 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 933 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2020 | 1920 | 0.100 |
Why?
|
| Internet | 1 | 2015 | 449 | 0.090 |
Why?
|
| Electrocardiography | 2 | 2024 | 523 | 0.090 |
Why?
|
| Communication | 2 | 2023 | 546 | 0.070 |
Why?
|
| Registries | 2 | 2021 | 801 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2017 | 745 | 0.060 |
Why?
|
| Computers | 1 | 2024 | 49 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2024 | 88 | 0.050 |
Why?
|
| Chest Pain | 1 | 2024 | 81 | 0.050 |
Why?
|
| Lidocaine | 1 | 2022 | 30 | 0.050 |
Why?
|
| Triage | 1 | 2024 | 109 | 0.050 |
Why?
|
| Conscious Sedation | 1 | 2022 | 38 | 0.050 |
Why?
|
| Workflow | 1 | 2023 | 63 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2024 | 184 | 0.050 |
Why?
|
| Research | 1 | 2024 | 188 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2022 | 68 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2023 | 113 | 0.050 |
Why?
|
| Documentation | 1 | 2023 | 128 | 0.050 |
Why?
|
| Heart Rate | 1 | 2023 | 307 | 0.050 |
Why?
|
| Bandages | 1 | 2021 | 15 | 0.050 |
Why?
|
| Methadone | 1 | 2022 | 127 | 0.050 |
Why?
|
| Geriatric Assessment | 1 | 2022 | 159 | 0.050 |
Why?
|
| Decision Trees | 1 | 2021 | 51 | 0.050 |
Why?
|
| Fever | 1 | 2021 | 61 | 0.040 |
Why?
|
| Uncertainty | 1 | 2020 | 33 | 0.040 |
Why?
|
| Hospitals | 1 | 2024 | 375 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2023 | 459 | 0.040 |
Why?
|
| Software | 1 | 2023 | 367 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2024 | 5283 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 315 | 0.040 |
Why?
|
| Opiate Substitution Treatment | 1 | 2022 | 187 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2023 | 342 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 1561 | 0.040 |
Why?
|
| Focus Groups | 1 | 2020 | 288 | 0.040 |
Why?
|
| Cough | 1 | 2021 | 182 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 525 | 0.040 |
Why?
|
| Algorithms | 1 | 2023 | 976 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 396 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 813 | 0.040 |
Why?
|
| Risk Factors | 2 | 2017 | 4982 | 0.040 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2017 | 36 | 0.040 |
Why?
|
| Body Temperature Regulation | 1 | 2017 | 20 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2017 | 22 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 56 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 61 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2017 | 52 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 677 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 244 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1236 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 3065 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 409 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 146 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 270 | 0.030 |
Why?
|
| Mass Screening | 1 | 2021 | 645 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 902 | 0.030 |
Why?
|
| Patient Selection | 1 | 2017 | 464 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 1232 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2017 | 841 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 4266 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 2373 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 5822 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2511 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 3614 | 0.020 |
Why?
|